Regulation
Cannabis in Africa: Current State of Affairs (2026)
Add MyCannabis.com to your preferred sources on Google
Cannabis laws in Africa differ sharply by country and by activity. Permission to grow an export crop, approval of a medicine, an industrial-hemp licence and protection for private adult use are different legal arrangements. None should be treated as a continent-wide right to buy, possess or carry cannabis across a border.
Several countries have moved from policy announcements to functioning licensing systems, while others still have legislation awaiting commencement or supporting rules. South Africa stands apart for its protection of adults’ private personal use. Most reforms discussed here concern regulated medical, scientific or industrial activity.
Where Is Cannabis Legal in Africa?
The following comparison covers selected countries with significant reforms. It is not an exhaustive list of African jurisdictions or a count of countries where cannabis is simply “legal.” Each country guide explains the relevant conditions and sources.
| Country | Key legal distinction | What to verify |
|---|---|---|
| South Africa | Adults have constitutional protection for private personal use and cultivation. Recreational retail sales are not generally authorised. | The 2024 private-purposes Act remains listed as awaiting commencement; draft quantities are not settled legal limits. |
| Lesotho | Licensed medical and scientific activity is permitted. Recreational use remains prohibited. | The specific licence, revised fees and lawful patient-supply route. |
| Zimbabwe | Medical-production licences and separate hemp permits exist. They do not legalise recreational use. | July 2026 production amendments, implementation of announced fee cuts, and product registration. |
| Malawi | The 2020 Act regulates medicinal, scientific and industrial cannabis, including a patient-card pathway. | Current provider availability, authorised varieties and the amended fee schedule; the 2024 chamba bill was not enacted by its parliamentary passage alone. |
| Zambia | The hemp law commenced in 2025 and the Controlled Substances Act in 2026. The separate Cannabis Act remains listed as uncommenced. | The legal basis for the particular medical, cultivation or trade activity. |
| Uganda | The 2024 narcotics law provides controlled licensing powers and prohibits unauthorised cultivation and possession. | Health-ministry cultivation authorisation and the relevant drug-authority approvals. |
| Morocco | Medical, pharmaceutical and industrial activities are regulated by ANRAC. Recreational use remains illegal. | Designated cultivation areas, cooperative participation and finished-product approval. |
| Ghana | Licensed cannabis must meet the 0.3% THC ceiling and approved purposes. First cultivation licences were announced in July 2026. | Activity-specific NACOC licensing and any required finished-product registration. |
| Rwanda | A 2021 order establishes regulated medical and research activity, cultivation and trade. | Ministerial and professional authorisations; an export project does not establish general pharmacy access. |
| Botswana | The 2025 Cannabis Act and 2026 regulations established a medical, scientific, research and industrial framework. | National Cannabis Control Authority licensing, approved sites and the scope of pilot permissions. |
South Africa: Private Adult Use Is a Distinct Model
The 2018 Constitutional Court judgment protects adults’ use, possession and cultivation in private for personal consumption. It did not authorise buying and selling cannabis. A membership club or private venue does not automatically make commercial supply lawful.
The government’s register for the Cannabis for Private Purposes Act 2024 still states that commencement is to be proclaimed. Proposed plant and possession quantities in the February 2026 draft regulations should therefore not be presented as enacted allowances. It is misleading both to describe South Africa as an unrestricted retail market and to say that no African country protects non-medical personal cannabis use.
Recent Changes Beyond the Older Country Lists
Botswana is a notable addition. Its 2026/27 agriculture budget statement says regulations were published on January 12, 2026, the National Cannabis Control Authority began operating, and two companies received pilot cultivation licences. Those milestones concern a regulated industry, not recreational legalisation.
Uganda also requires updated terminology. The Narcotic Drugs and Psychotropic Substances (Control) Act 2024 gives the health minister cultivation-licensing powers and the drug authority medical licensing functions. Its commencement was April 14, 2025. Reports about the earlier law being struck down in 2023 should not be treated as proof that cannabis is now unrestricted.
Ghana’s first cultivation licences and Morocco’s expanding regulated production show why dated milestones matter. An application portal, a licence, an operating farm and a completed sale provide different evidence of progress. Figures from one stage should not be substituted for another.
Medical Production Does Not Guarantee Patient Access
Export-oriented production can exist without an easily accessible domestic patient programme. Conversely, medical law may provide limited prescribing, registration or import pathways even where there is no dispensary network. A blanket “medical cannabis is legal” or “patients have no legal route” can conceal these differences.
Zimbabwe’s regulator describes medical production primarily for export and local research, alongside a separate product-registration route for hemp-based CBD medicines. Malawi’s statute provides for qualifying patient cards, while the availability of authorised providers requires checking. Zambia’s Controlled Substances Act, effective in 2026, must be considered when assessing its medicinal framework.
Patients should establish the actual product, authorised prescriber, supply channel and any import requirements. A registered medicine is not interchangeable with an unregulated oil, a cosmetic or a product carrying the same cannabinoid name.
Hemp Thresholds Are Not Uniform
Ghana’s cultivation programme uses a 0.3% THC ceiling. Zimbabwe’s hemp definition and Malawi’s statutory industrial-hemp definition use 1%, subject to their respective rules. Morocco reserves cultivation above its non-medical industrial threshold for medical and pharmaceutical industries. The same seed or extract may therefore be treated differently across borders.
Even when plant material satisfies a hemp definition, its cultivation, transport and finished products may require separate approvals. A crop threshold is not a general exemption from medicines, food, cosmetics or import law.
What Determines Whether a Project Can Succeed?
A credible project needs more than a suitable climate and a licence. Farmers and investors should establish:
- Whether the proposed activity is currently authorised and applications are open.
- Who may hold the licence and whether cooperative membership or local ownership is required.
- The approved variety, site, security and cultivation requirements.
- A buyer whose intended use and import permissions match the product.
- Testing, processing, transport and registration costs alongside regulatory fees.
- Payment terms and a realistic route from harvested material to a saleable product.
Lower fees can reduce an entry cost without resolving financing, product quality or market access. Harvest tonnage and licence counts should not be presented as export earnings or evidence that small farmers have received the projected benefits.
Culture, Local Varieties and Evidence
Africa is not a single cannabis culture. Descriptions of historical practices should identify the community, place, period and evidence, rather than attribute one spiritual or medical tradition to an entire continent. Historical medicinal use also does not establish clinical effectiveness for a particular condition.
Names such as Malawi Gold, Durban Poison or Beldia can carry cultural and commercial significance. A name alone does not verify a plant’s genetics, cannabinoid content, effects or legal status. Product-specific testing and traceability matter.
Cultural significance does not necessarily create a legal exemption. Malawi’s High Court rejected a religious-use cannabis challenge in May 2026, illustrating the difference between a claimed religious practice and the law’s current protection.
What This Means for Travellers and Consumers
Check the destination country’s rules for the precise product and activity. A foreign prescription, medical card, low-THC label or private-use protection in another country does not automatically authorise importation, purchase or possession. Licensed cultivation in a country is especially poor evidence that tourists may lawfully buy recreational cannabis there.
For further perspectives on the industry’s development, our interviews with Gaspard de Villeneuve and Wilfred Maina present industry and advocacy viewpoints. Those perspectives complement, rather than establish, the legal position documented in the country guides.
